MapLight Therapeutics, Inc.
MPLT
$20.55
$0.613.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -29.42M | -29.85M | -22.34M | -19.02M | |
| Total Depreciation and Amortization | 136.00K | 136.00K | 166.00K | 187.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -115.00K | 920.00K | 167.00K | -358.00K | |
| Change in Net Operating Assets | -2.39M | -5.18M | -3.54M | -667.00K | |
| Cash from Operations | -31.79M | -33.97M | -25.55M | -19.85M | |
| Capital Expenditure | -31.00K | -66.00K | -- | -374.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -135.56M | 17.50M | 37.50M | 9.01M | |
| Cash from Investing | -135.59M | 17.43M | 37.50M | 8.64M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 104.00K | 3.00K | 5.00K | 7.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 198.87M | -- | -- | 0.00 | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -916.00K | -159.00K | -52.00K | -214.00K | |
| Cash from Financing | 198.06M | -156.00K | -47.00K | -207.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 30.68M | -16.69M | 11.90M | -11.42M | |